Genzyme CEO Henri A. Termeer On Big Pharma’s Transformation To Becoming Leaner Machines: An Interview With PharmAsia News (Part 1 of 2)
This article was originally published in PharmAsia News
Executive Summary
Genzyme CEO Henri A. Termeer has seen his company grow from a small entrepreneurial venture into one of the world's largest biotech companies. Having held several prestigious positions like deputy chairman of the Federal Reserve Bank of Boston's board of directors and chairman of the board of Medical Simulation Corp, Termeer is recognized globally for his contributions in the field of biotechnology. With a growth record of 20 percent annually for the past five years, Termeer is now looking beyond American shores to keep with the growth momentum. In an interview with PharmAsia News' India bureau during a World Economic Forum meeting in New Delhi, Termeer speaks on the challenges of the global pharmaceutical industry and the role of emerging markets like India and China.